Tag: Screening

20 new anticancer therapeutics, two new devices, two minimally invasive tests, AI-based tools for early detection approved by FDA

Sensitivity ranged from 0.095 to 0.998; specificity from 0.657 to 1.0; AUC from 0.52 to 1.0 across tests

Greatest increases seen among underrepresented communities including Black adults and those with lower education

Detection rates up for lesions not routinely detected on four-chamber view but visible on outflow tract views

Highest posterior probabilities seen with mood and anxiety disorder co-occurrence

Guideline deviations include back unsupported, forearm not resting on surface, manual and not electronic device, feet not flat on floor

In one health system, including personalized risk in a decision aid or provider notification increased uptake of stool testing

Child-focused screening for MEB problems should start at age 6 months and continue at 12-, 24-, and 36-month health supervision visits

Many report navigating the screening process without sufficient information or emotional support

Diagnosis of distant-stage cervical cancer was 84 percent higher and deaths were 96 percent higher in low-screening counties